Y-mAbs Therapeutics
YMAB
YMAB
45 hedge funds and large institutions have $222M invested in Y-mAbs Therapeutics in 2019 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 14 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
45
Holders Change
+3
Holders Change %
+7.14%
% of All Funds
0.98%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
13
Reduced
14
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
$18.8M |
2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
$16.8M |
3 |
AllianceBernstein
Nashville,
Tennessee
|
$17.4M |
4 |
BlackRock
New York
|
$9.68M |
5 |
Vanguard Group
Malvern,
Pennsylvania
|
$7.46M |